ROBINS HARLAN S — SEC Form 4 filings
SEC reporting owner CIK 1780851. 15 Form 4 filings on record with FilingPulse; latest filed 2026-07-23.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-03-06 to 2026-07-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 13 filings — 1,756,065 shares, $30,841,281 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 278,698 shares @ $21.72 ($6,053,321) in Adaptive Biotechnologies Corp, filed 2026-07-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Chief Scientific Officer | 15 | — | 21 legs · 1,756,065 sh · $30,841,281 | 10 |
Form 4 filings — ROBINS HARLAN S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-23 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 284,800 @ $6.55 · Sale (S): 278,698 @ $21.72 · Sale (S): 213,702 @ $22.12 · Option exercise (M): 284,800 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 239,351 @ $21.74 · Sale (S): 146,889 @ $22.45 | EDGAR |
| 2026-06-17 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 100,000 @ $17.37 · Sale (S): 6,160 @ $18.01 | EDGAR |
| 2026-04-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 10,000 @ $14.85 | EDGAR |
| 2026-03-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 140,666 @ $13.17 · Sale (S): 329,600 @ $13.17 | EDGAR |
| 2026-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 127,813 @ $0 · Grant/award (A): 709,220 @ $0 | EDGAR |
| 2026-03-04 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 10,000 @ $15.72 · Sale (S): 14,233 @ $16.52 | EDGAR |
| 2026-02-04 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 34,668 @ $18.60 · Sale (S): 8,120 @ $19 | EDGAR |
| 2026-01-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 10,000 @ $16.44 | EDGAR |
| 2025-12-05 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 27,212 @ $18.61 · Sale (S): 10,000 @ $16.61 | EDGAR |
| 2025-11-12 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 10,000 @ $14.82 | EDGAR |
| 2025-05-05 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 68,412 @ $6.32 · Sale (S): 68,412 @ $7.35 · Option exercise (M): 68,412 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 1,698 @ $6.32 · Sale (S): 1,698 @ $9 · Option exercise (M): 1,698 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 355,000 @ $0 · Sale (S): 40,603 @ $6.98 · Sale (S): 56,053 @ $6.99 | EDGAR |
| 2024-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 354,610 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780851 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →